Literature DB >> 8111367

Functional imprinting and epigenetic modification of the human SNRPN gene.

C C Glenn1, K A Porter, M T Jong, R D Nicholls, D J Driscoll.   

Abstract

The SNRPN gene encodes a small nuclear ribonucleoprotein subunit, SmN, thought to be involved in splicing of pre-mRNA. A closely related protein, SmB/B', is constitutively expressed in all tissues except the brain, where SmN is predominantly expressed. The mouse homolog of the SNRPN gene has been shown to be functionally imprinted in mouse brain, being expressed only from the paternally derived chromosome. SNRPN has been mapped to human chromosome 15q11-q13 within the shortest region of deletion overlap for the Prader-Willi syndrome. We have now demonstrated functional imprinting of the human SNRPN gene using reverse transcription followed by the polymerase chain reaction (RT-PCR). No expression was observed in cultured skin fibroblasts of Prader-Willi patients, but was found in all Angelman patients and normal controls examined. We have also demonstrated a parent-specific DNA methylation imprint within intron 5 of the SNRPN gene, which suggests an epigenetic mechanism by which parent-specific expression of this gene might be inherited. Our findings indicate that SNRPN is expressed only from the paternally derived chromosome 15 in humans and therefore may fulfill one major criterion for being involved in the pathogenesis of the Prader-Willi syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111367     DOI: 10.1093/hmg/2.12.2001

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

Review 1.  Genomic imprinting: implications for human disease.

Authors:  J G Falls; D J Pulford; A A Wylie; R L Jirtle
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Counselling dilemmas associated with the molecular characterisation of two Angelman syndrome families.

Authors:  H L Gilbert; J L Buxton; C T Chan; T McKay; S Cottrell; S Ramsden; R M Winter; M E Pembrey; S Malcolm
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

3.  Dynamic methylation adjustment and counting as part of imprinting mechanisms.

Authors:  R Shemer; Y Birger; W L Dean; W Reik; A D Riggs; A Razin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination, and nondisjunction.

Authors:  S Toth-Fejel; S Olson; K Gunter; F Quan; J Wolford; B W Popovich; R E Magenis
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

5.  Balanced translocation 46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome.

Authors:  J M Conroy; T A Grebe; L A Becker; K Tsuchiya; R D Nicholls; K Buiting; B Horsthemke; S B Cassidy; S Schwartz
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

6.  Novel paternally expressed intergenic transcripts at the mouse Prader-Willi/Angelman Syndrome locus.

Authors:  Victoria L Buettner; Andrew M Walker; Judith Singer-Sam
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

7.  Ubiquitous expression and imprinting of Snrpn in the mouse.

Authors:  J A Barr; J Jones; P H Glenister; B M Cattanach
Journal:  Mamm Genome       Date:  1995-06       Impact factor: 2.957

8.  A molecular and cytogenetic study in Finnish Prader-Willi patients.

Authors:  H Kokkonen; M Kähkönen; J Leisti
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

9.  DNA diagnosis of Prader-Willi and Angelman syndromes with the probe PW71 (D15S63).

Authors:  A M van den Ouweland; M N van der Est; E Wesby-van Swaay; T S Tijmensen; F J Los; J O Van Hemel; R C Hennekam; H J Meijers-Heijboer; M F Niermeijer; D J Halley
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 10.  Epilepsy in Prader-Willi syndrome: clinical, diagnostic and treatment aspects.

Authors:  Alberto Verrotti; Claudia Soldani; Daniela Laino; Renato d'Alonzo; Salvatore Grosso
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.